Multi-disciplinary community-based group intervention for fibromyalgia: a pilot randomized controlled trial.

Publication Year: 2023

DOI:
10.1007/s00296-023-05403-5

PMCID:
PMC10587329

PMID:
37566253

Journal Information

Full Title: Rheumatol Int

Abbreviation: Rheumatol Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Rheumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestNeil Pearson is the owner of Pain Care U Education Inc, a for-profit business with the goal of decreasing the impact of pain on society through the platforms of yoga and pain science. There are no other conflicts of interest to declare. Conflict of interest Neil Pearson is the owner of Pain Care U Education Inc, a for-profit business with the goal of decreasing the impact of pain on society through the platforms of yoga and pain science. There are no other conflicts of interest to declare."

Evidence found in paper:

"Funding The funding for this research was through The Canadian Initiative for Outcomes in Rheumatology Care."

Evidence found in paper:

"This pilot study used a non-blinded randomized control trial design with two parallel groups comparing a community-based multidisciplinary group intervention to usual care for individuals diagnosed with FM. A pilot was deemed an appropriate approach given the multi-component nature of the intervention, and that it included modifications made to our original intervention following a feasibility trial []. Participants were randomized into either the intervention group or control group using block randomization with a block size of four using Random Allocation Software []. Data collection took place over two years, between September 2017 and June 2019. The study protocol was a registered clinical trial (NCT03270449), received institutional ethics board approval on September 15 2017 (H17-01782-A010), and informed consent was obtained from all participants at enrollment."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025